Tag
GILEAD SCIENCES
Gilead Sciences Inc. has announced a new licensing deal to provide its twice-yearly experimental HIV prevention drug, lenacapavir, to six generic drug manufacturers to produce affordable versions of the drug for 120 low- and middle-income countries, including Nigeria, once regulatory approval is secured.
The remdesivir drug is manufactured by American pharmaceutical company, Gilead Sciences. Data from Coronavirus trial testing of the drug showed that patients who took it recovered within eleven days.